1-(2,6-dimethylmorpholin-4-yl)-3-[(5-imino-7-methoxy-2,3-dihydro-1H-imidazo[1,2-c]quinazolin-8-yl)oxy]propan-2-ol
C20H29N5O4 — CID 137098214
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-(2,6-dimethylmorpholin-4-yl)-3-[(5-imino-7-methoxy-2,3-dihydro-1H-imidazo[1,2-c]quinazolin-8-yl)oxy]propan-2-ol
1-(2,6-dimethylmorpholin-4-yl)-3-[(5-imino-7-methoxy-2,3-dihydro-1H-imidazo[1,2-c]quinazolin-8-yl)oxy]propan-2-ol (PubChem CID 137098214) has the molecular formula C20H29N5O4 and a molecular weight of 403.48 g/mol. Its IUPAC name is 1-(2,6-dimethylmorpholin-4-yl)-3-[(5-imino-7-methoxy-2,3-dihydro-1H-imidazo[1,2-c]quinazolin-8-yl)oxy]propan-2-ol.
Molecular Properties
| Compound Name | 1-(2,6-dimethylmorpholin-4-yl)-3-[(5-imino-7-methoxy-2,3-dihydro-1H-imidazo[1,2-c]quinazolin-8-yl)oxy]propan-2-ol |
|---|---|
| PubChem CID | 137098214 |
| Molecular Formula | C20H29N5O4 |
| Molecular Weight | 403.48 g/mol |
| Exact Mass | 403.22 |
| IUPAC Name | 1-(2,6-dimethylmorpholin-4-yl)-3-[(5-imino-7-methoxy-2,3-dihydro-1H-imidazo[1,2-c]quinazolin-8-yl)oxy]propan-2-ol |
| SMILES | [H]/N=c1\nc2c(OC)c(OCC(O)CN3CC(C)OC(C)C3)ccc2c2n1CCN2 |
| InChI | InChI=1S/C20H29N5O4/c1-12-8-24(9-13(2)29-12)10-14(26)11-28-16-5-4-15-17(18(16)27-3)23-20(21)25-7-6-22-19(15)25/h4-5,12-14,21-22,26H,6-11H2,1-3H3/b21-20+ |
| InChIKey | VIYWXRDWQAKQGW-QZQOTICOSA-N |
| XLogP | 0.80 |
| TPSA | 104.86 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 9 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 29 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 403.48 |
| LogP ≤ 5 | 0.80 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 9 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 137098214 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.